Global perspective of tobacco habits and lung cancer: A lesson for third world countries

European Journal of Cancer Prevention

Volumn 8, Issue 4, 1999, Pages 271-279

  Pandey, M ^a   Mathew, A ^a   Nair, M K ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Epidemiology; Lung cancer; Morbidity; Mortality; Smoking; Tobacco; Trends

Indexed keywords

CANCER MORTALITY; DEVELOPING COUNTRY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; HUMAN; LUNG CANCER; PREVALENCE; PRIORITY JOURNAL; REVIEW; SMOKING;

EID: 0032870827     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-199908000-00002     Document Type: Review

References (58)

1. Armitage AK, Turner DM (1970). Absorption of nicotine in cigarette and cigar smoke through oral mucosa. Nature 226: 1231-2.
2. Assembly of Life Sciences (1981). The Health Effects of Nitrate, Nitrite and N-Nitroso-Compounds; Washington, DC, National Academy Press.
3. Bombay Cancer Registry (1998). National Cancer Registry Project (ICMR). Cancer Morbidity and Mortality in Greater Bombay, 1995; Indian Cancer Society, Mumbai, India.
4. Boyle P, Maisonneuve P (1995). Lung cancer and tobacco smoking. Lung Cancer 12: 167-81.
5. Cancer Registry, Trivandrum (1998). Technical Report 1996-97; Regional Cancer Centre Trivandrum, Kerala, India.
6. Centres for Disease Control (1987). Smoking attributable mortality and years of potential life lost - United States, 1984. MMWR Morb Mortal Wkly Rep 36: 693-7.
7. Cigarette smoking among adults - United States, 1994 (1996). MMWR, Morb Mortal Wkly Rep 45: 588-90.
8. Cinciripini PM, Hecht SS, Henningfield JE, Manley MW, Kramer BS (1997). Tobacco addiction: implications for treatment and cancer prevention. J Natl Cancer Inst 89: 1852-67.
9. Cloos J, Spitz MR, Schantz SP et al. (1996). Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst 88: 530-5.
10. Coleman MP, Esteve J, Damieck P, Arslan A, Renard H (1993). Trends in Cancer Incidence and Mortality; IARC Scientific Publications no. 143, IARC, Lyon, pp. 311-342.
11. Dipple A (1994). Reactions of Polycyclic Aromatic Hydrocarbons with DNA; IARC Scientific Publication no. 125, IARC, Lyon, pp. 106-29.
12. Doll R, Peto R, Wheatley K, Gray R, Sutherland I (1994). Mortality in relation to smoking: 40 Years observation on a male British doctor. Br Med J 309: 901-11.
13. Fleckseder R (1936). Veber den bronchialkrebs and einge seiner, entstchugsbedingungin. Munch Med Wochenscher 36: 1585-93.
14. Gao YT, Blot WJ, Zheng W (1987). Lung cancer among Chinese women. Int J Cancer 40: 604-9.
15. Greenblat MS, Bennett WP, Hollstein M, Harris CC (1994). Mutations in the p53 tumour suppresser gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-78.
16. Grey N (1993). Global overview of the tobacco problems. Lung Cancer 9: 17-28.
17. Hammond EC, Garfinkel L, Scidman M, Lew EA (1976). Tar and nicotine content of cigarette smoke in relation to death rates. Environ Res 12: 262-74.
18. Hecht SS (1996). Recent studies on mechanisms of bioactivation and dctoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanon (NNK), a tobacco specific lung carcinogen. Crit Rev Toxicol 26: 163k-81.
19. Hecht SS, Hoffman D (1991). 4-(Methylnitrosamino)-1-(3-pyridyl-1-Butanone, A Nicotine Derived Tobacco Specific Nitrosamine and Cancer of the Lung and Pancreas in Humans (eds Burgge J, Curran T, Harlow E, McCarmik F); Cold Spring Harbor, New York.
20. Hoffmann D, Hecht SS (1989). Advances in tobacco carcinogenesis. In Chemical Carcinogenesis and Mutagenesis (ed Grover P); Springer, London, pp. 63-102.
21. Hoffmann D, Hecht SS (1990). Advances in tobacco carcinogenesis. In Handbook of Experimental Pharmacology (eds Cooper CS, Grover PI); Heidelberg, Springer 63: 102.
22. Hoffmann D, Hoffmann I, Wynder EL (1991). Relevance to human cancer of N-nitroso compound, tobacco smoke and mycotoxins. In Lung Cancer and Changing Cigarette (eds O'Neill IK, Chen J, Bartsch M); IARC Scientific Publication no. 105, IARC, Lyon, pp. 449-59.
23. Hoffmann D, Brunnemann KD, Hoffmann I, Riverson A, Hecht SS (1992). Control of tobacco-related cancer and other diseases. In Advances in Tobacco Carcinogenesis. II. Cigarette Smoke (eds Gupta PC, Hammer JE, Murti PR); proceedings of an International Symposium, 1990, Oxford University Press, Bombay, pp, 205-16.
24. International Agency for Research on Cancer (1986). Monograph on the Evaluation of Carcinogenic Risk to Humans. Tobacco Smoking, vol. 38; IARC, Lyon.
25. Jin X, Wu X, Rotu JA et al. (1995). Higher young cancer risk for younger African-Americans with Pro/Pro p53 genotype. Carcinogenesis 16: 2205-8.
26. Johnston LD, O'Malley PM, Bachman JG (1996). National Survey Results on Drug Use from Monitoring the Future Study, 1975-1995, vol, I. Secondary School Students; Rockville (MD), National Institute on Drug Abuse. NIH Publication no. 97, p. 4139.
27. Kaujman DW, Palmer JR, Rosenberg L et al. (1989). Tar content of cigarettes in relation to lung cancer. Am J Epidemiol 129: 703-11.
28. Levin ML, Goldstein H, Gerharot PR (1950). Cancer and tobacco smoking. J Am Med Assoc 143: 336-38.
29. Lubin LH, Blot WJ, Berrino F et al. (1984). Patterns of lung cancer risk according to type of cigarettes smoked. Int J Cancer 33: 569-76.
30. MacLennan R, de Costa J, Day NE et al. (1977). Risk factors for lung cancer in Singapore Chinese, population with high incidence rates. Int J Cancer 20: 854-60.
31. Muller FH (1940). Tabaksmusbrauch and lungenkarzinoma. Z Krebsfarsch 49: 57-85.
32. Natural Background Radiation Cancer Registry, Karunagappally (1997). Rural Population Cancer Registry, Technical Report-2, 1990-1994; Regional Cancer Centre, Trivandrum, Kerala, India.
33. Parkin DM, Sasco AJ (1993). Lung cancer. Worldwide variation in occurrence and proportion attributable to tobacco use. Lung Cancer 9: 1-16.
34. Parkin DM, Pisani P, Ferley J (1993). Estimates of the world wide incidence of eighteen major cancers in 1985. Int J Cancer 54: 594-606.
35. Parkin DM, Whelan SL, Ferlay J, Raymond, Young J (1997). Cancer Incidence in Five Continents, Vol VII; IARC Scientific Publication no. 143, IARC, Lyon.
36. Pindborg JJ, Murti P, Bhonsle RB, Gupta PC (1992). Control of tobacco-related cancers and other diseases. In Global Aspects of Tobacco Use and Its Implications for Oral Health (eds Gupta PC, Hamner JE III, Murti PR); proceedings of an International Symposium, 1990, TIFR, Bombay, Oxford University Press, Bombay, pp. 13-23.
37. Peto R (1994). Smoking and death: The past 40 years and the next 40. Br Med J 309: 937-9.
38. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr (1996). Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 39: 1268-78.
39. Perera FP (1996). Molecular epidemiology: in sight into cancer susceptibility, risk assessment and prevention. J Natl Cancer Inst 88: 496-509.
40. Polyneclear Aromatic Compounds, Part I (1983). Chemical, environmental and experimental data. IARC Monograph. Eval Carcinogenic Risk Chem Hum 32: 62-6
41. Population Based Cancer Registry, Ahmedabad (1994). Urban Agglomeration Area. Biennial Report 1990-91; Gujarat Cancer And Research Institute, Ahmedabad, India.
42. National Cancer Registry Programme (NCRP) (1993). Biennial Report 1988-1989. An Epidemiological Study; Indian Council of Medical Research, New Delhi, 40.
43. Roberts DL (1988). Natural tobacco flavor. Recent advances. Tob Sci 14: 49-81.
44. Rodenhuis S, Slebos RJ (1992). Clinical significance of ras oncogene activation in human lung cancer. Cancer Res 52(Suppl 9):2665s-9s.
45. Sanghvi LD (1992). Control of tobacco-related cancers and other diseases. In Challenges in Tobacco Control in India, A Historical Perspective (eds Gupta PC, Hamner JE III, Murti PR); Proceedings of an International Symposium, 1990, TIFR, Bombay, Oxford University Press, Bombay, pp. 47-55.
46. Schairer E, Schoniger E (1943). Lung cancer and tobacco consumption. Z Krebsforsch 54: 261-9 (in German).
47. Schrek R, Baker LA, Ballard GB, Dolgoll S (1950). Tobacco smoking as an etiological factor in disease. I. Cancer. Cancer Res 10: 49-58.
48. Singer B, Essigmann JM (1991). Site-specific mutagenosis: Retrospective and prospective. Carcinogenesis 12: 949-55.
49. Surveillance for selected tobacco-use behaviour - United States (1994). MMWR Morb Mortal Wkly Rep 43: 1-43.
50. The health benefits of smoking cessation (1990). A Report of the Surgeon General Rockville (MD): Department of Health and Human Services; Public Health and Health Promotion Office on Smoking and Health.
51. Spitz MR, Fueger JJ, Halabi S et al. (1993). Mutagen sensitivity in upper aerodigestive tract: A casencontrol analysis. Cancer Epidemiol Biomarker Prev 2: 329-33.
52. Spitz MR, Hsu TC, Wu X et al. (1995). Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarker Prey 4: 99-103.
53. Tobacco use and usual source of cigarettes among high school students - United States, 1995 (1996). MMWR Morb Mortal Wkly Rep 45; 413-18.
54. Tylecote FE (1927). Cancer of the lung. Lancet 2: 256-9.
55. Use of Smokeless Tobacco Among Adults - United States, 1991 (1993). MMWR Morb Mortal Wkly Rep 42: 263-6. [Eratum published MMWR Morb Mortal Wkly Rep (1992) 42: 382.1
56. Walker WJ, Brin BN (1988). US lung cancer morality and declining cigarette tobacco consumption. J Clin Epidemiol 41: 179-85.
57. Wynder EL, Graham ES (1950). Tobacco smoking as a possible etiologic factor in bronchogenic carcinoma: a study of 684 proved cases. J Am Med Assoc 143: 329-36.
58. Zang EA, Wynder EL (1996). Differences in lung cancer risk between men and women: examination of evidence. J Natl Cancer Inst 88: 183-92.